Latest filing published 12 Jan 2021 for Alaunos Therapeutics, Inc., €45k.
Filing timeline
BuySaleInsider track record
Kevin G. Lafond: trading record in brief
Kevin G. Lafond is a declared insider of Alaunos Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 22 filings; the first trade dates from 31 December 2013 and the latest from 8 January 2021.
On the market, this insider has only sold: 6 sales, €682k in total. Besides market trades, the filings include 13 share grants and 3 option exercises. Since January 2021: no purchases and 1 sale on the market.
On 12 January 2021 came the latest disclosure, an open-market sale for €45k in Alaunos Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kevin G. Lafond
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18,020 shares@ US$3.0911.2% of flowCommon StockSEC:0001209191-21-003244:0
- 18,000 shares0Common StockSEC:0001209191-20-005785:0
- 21,570 shares@ US$4.5537.5% of flowCommon StockSEC:0001209191-20-001176:0
- 11,667 shares@ US$2.8512.9% of flowCommon StockSEC:0001209191-19-058365:0
- 11,667 shares@ US$5.2523.8% of flowCommon StockSEC:0001209191-19-058365:1
- 37,122 shares0Common StockSEC:0001209191-19-002787:0
- 17,667 shares@ US$1.668.3% of flowCommon StockSEC:0001209191-19-000588:0
- 13,100 shares@ US$1.666.1% of flowCommon StockSEC:0001209191-19-000588:1
- 9,334 shares@ US$1.874.9% of flowCommon StockSEC:0001209191-19-000588:2
- 53,000 shares0Common StockSEC:0001209191-18-001005:0
- 13,100 shares@ US$4.1412.7% of flowCommon StockSEC:0001209191-18-001005:1
- 9,333 shares@ US$4.149.0% of flowCommon StockSEC:0001209191-18-001005:2
- 9,333 shares@ US$5.3513.2% of flowCommon StockSEC:0001209191-17-001003:1
- 39,300 shares0Common StockSEC:0001209191-17-001003:0
- 28,000 sharesCommon StockSEC:0001209191-16-088692:0
- 26,666 shares@ US$9.60Common StockSEC:0001209191-15-050757:0
- 3,334 shares@ US$0.80Common StockSEC:0001209191-15-050757:1
- 3,334 shares@ US$9.70Common StockSEC:0001209191-15-050757:2
- 27,500 shares@ US$2.30Common StockSEC:0001209191-15-050757:3
- 27,500 shares@ US$9.70Common StockSEC:0001209191-15-050757:4
- 4,690 shares@ US$5.03Common StockSEC:0001209191-15-000210:0
- 4,690 shares@ US$4.34Common StockSEC:0001209191-14-000745:0
22 of 22 declarations